Literature DB >> 17976949

Sorafenib and surgical complications: a case report of adverse reaction to sorafenib during treatment for renal cell carcinoma.

F C S Eng1, A M Easson, E Szentgyorgyi, J J Knox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17976949     DOI： 10.1016/j.ejso.2007.09.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN： 0748-7983            Impact factor:   4.424


× No keyword cloud information.
  4 in total

1.  Bowel Perforation After Treatment with Sorafenib: A Case Report and Review of Literature.

Authors:  Shadi Hamdeh; Smrity Upadhyay; Nabin Khanal; Stephen Lanspa
Journal:  J Gastrointest Cancer       Date:  2016-12

2.  Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer.

Authors:  Chul Kim; Jae-Lyun Lee; Yoon Hee Choi; Byung Woog Kang; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Yoon-Koo Kang
Journal:  Invest New Drugs       Date:  2010-09-14       Impact factor: 3.850

3.  Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.

Authors:  Hideaki Takeyama; Toru Beppu; Takaaki Higashi; Takayoshi Kaida; Kota Arima; Katsunobu Taki; Katsunori Imai; Hidetoshi Nitta; Hiromitsu Hayashi; Shigeki Nakagawa; Hirohisa Okabe; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Motohiko Tanaka; Yutaka Sasaki; Hideo Baba
Journal:  Surg Today       Date:  2017-11-07       Impact factor: 2.549

Review 4.  Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.

Authors:  Maudy Walraven; Petronella O Witteveen; Martijn P J Lolkema; R van Hillegersberg; Emile E Voest; H M W Verheul
Journal:  Angiogenesis       Date:  2010-12-29       Impact factor: 9.596
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.